-
Half of Physician Directors of NCI Cancer Centers Receive Industry Payments
drugs
August 16, 2019
In 2017, about half of physician directors of National Cancer Institute (NCI)-designated cancer centers received industry payments, according to a research letter published online in JAMA Internal Medicine.
-
Poll: Patients Want to Talk to Physicians About Self-Care
drugs
July 31, 2019
According to recent survey results, patients want more information from physicians on self-care.
-
Many Patients With Depression Do Not Need a Psychiatrist
drugs
July 18, 2019
Primary care doctors can detect and treat most cases of depression, according to a study published in the July/August issue of the Annals of Family Medicine.
-
Cuts in Trainee Doctor Hours Haven't Harmed Patients
drugs
July 12, 2019
Cutting back on the grueling hours that U.S. medical residents spend in training doesn't translate into poorer care, new research shows.
-
Capping Work Hours in Residency Does Not Impact Outcomes Later
drugs
July 12, 2019
Capping Work Hours in Residency Does Not Impact Outcomes Later.
-
Physicians Unaware of Breast Density Laws, Cancer Risk
drugs
June 27, 2019
Physicians unaware of breast density laws, cancer risk.
-
ACP Issues Position on Response to Physician Impairment
drugs
June 04, 2019
ACP Issues Position on Response to Physician Impairment.
-
High Costs Associated With Physician Burnout in U.S.
drugs
May 31, 2019
High Costs Associated With Physician Burnout in U.S.
-
2018 Saw More Employed Physicians Than Self-Employed
drugs
May 10, 2019
In 2018, employed physicians outnumbered self-employed physicians, according to a report from the American Medical Association (AMA).
-
Physician Views snap poll - Asking US ophthalmologists about RTH258, one of Novartis’ key growth drivers in waiting
firstwordpharma
April 25, 2019
Novartis recently filed RTH258 - otherwise known as brolucizumab - with the FDA for the treatment of wet age-related macular degeneration (AMD).